FHIR IG analytics
| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113883.3.464.1003.1259.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.1259/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259 |
| Version | 20240124 |
| Status | active |
| Date | 2024-01-24T01:11:59-05:00 |
| Name | SubstanceUseDisorderShortActingMedication |
| Title | Substance Use Disorder Short Acting Medication |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.) |
Resources that use this resource
Resources that this resource uses
Narrative
No narrative content found in resource
Source1
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.3.464.1003.1259",
"meta": {
"versionId": "10",
"lastUpdated": "2024-01-24T09:53:43.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "NCQA PHEMUR Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-03-10"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2024-01-24"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.3.464.1003.1259"
}
],
"version": "20240124",
"name": "SubstanceUseDisorderShortActingMedication",
"title": "Substance Use Disorder Short Acting Medication",
"status": "active",
"date": "2024-01-24T01:11:59-05:00",
"publisher": "NCQA PHEMUR",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1010600",
"display": "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film"
},
{
"code": "1010604",
"display": "buprenorphine 8 MG / naloxone 2 MG Sublingual Film"
},
{
"code": "1307056",
"display": "buprenorphine 4 MG / naloxone 1 MG Sublingual Film"
},
{
"code": "1307061",
"display": "buprenorphine 12 MG / naloxone 3 MG Sublingual Film"
},
{
"code": "1431076",
"display": "buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet"
},
{
"code": "1431102",
"display": "buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet"
},
{
"code": "1483744",
"display": "naltrexone hydrochloride 50 MG Oral Tablet"
},
{
"code": "1542390",
"display": "buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film"
},
{
"code": "1544851",
"display": "buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film"
},
{
"code": "1544854",
"display": "buprenorphine 6.3 MG / naloxone 1 MG Buccal Film"
},
{
"code": "1597568",
"display": "buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet"
},
{
"code": "1597573",
"display": "buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet"
},
{
"code": "1666338",
"display": "buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet"
},
{
"code": "1864412",
"display": "buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet"
},
{
"code": "197623",
"display": "disulfiram 250 MG Oral Tablet"
},
{
"code": "197624",
"display": "disulfiram 500 MG Oral Tablet"
},
{
"code": "351264",
"display": "buprenorphine 2 MG Sublingual Tablet"
},
{
"code": "351265",
"display": "buprenorphine 8 MG Sublingual Tablet"
},
{
"code": "351266",
"display": "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet"
},
{
"code": "351267",
"display": "buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet"
},
{
"code": "835726",
"display": "acamprosate calcium 333 MG Delayed Release Oral Tablet"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:9418c765-a928-4d2b-999a-138f3d891635",
"timestamp": "2025-05-23T22:30:23-04:00",
"total": 21,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1010600",
"display": "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1010604",
"display": "buprenorphine 8 MG / naloxone 2 MG Sublingual Film"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1307056",
"display": "buprenorphine 4 MG / naloxone 1 MG Sublingual Film"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1307061",
"display": "buprenorphine 12 MG / naloxone 3 MG Sublingual Film"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1431076",
"display": "buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1431102",
"display": "buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1483744",
"display": "naltrexone hydrochloride 50 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1542390",
"display": "buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1544851",
"display": "buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1544854",
"display": "buprenorphine 6.3 MG / naloxone 1 MG Buccal Film"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1597568",
"display": "buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1597573",
"display": "buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1666338",
"display": "buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1864412",
"display": "buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "197623",
"display": "disulfiram 250 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "197624",
"display": "disulfiram 500 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "351264",
"display": "buprenorphine 2 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "351265",
"display": "buprenorphine 8 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "351266",
"display": "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "351267",
"display": "buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "835726",
"display": "acamprosate calcium 333 MG Delayed Release Oral Tablet"
}
]
}
}
FHIR
FHIRsmith